Vimarsana
Biggest News Aggregation in the World

Page 5 - Intersect Ent Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intersect Ent Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intersect Ent Inc Today - Breaking & Trending Today

Critical Survey: Minerva Surgical (NASDAQ:UTRS) versus Intersect ENT (NASDAQ:XENT) - Vimarsana News

Critical Survey: Minerva Surgical (NASDAQ:UTRS) versus Intersect ENT (NASDAQ:XENT)

Minerva Surgical (NASDAQ:UTRS – Get Rating) and Intersect ENT (NASDAQ:XENT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk. Profitability This table compares Minerva Surgical and Intersect ENT’s […]

Calamos Advisors LLC Invests $5.53 Million in Intersect ENT, Inc. (NASDAQ:XENT) - Vimarsana News

Calamos Advisors LLC Invests $5.53 Million in Intersect ENT, Inc. (NASDAQ:XENT)

Calamos Advisors LLC purchased a new position in Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 202,386 shares of the medical equipment provider’s stock, valued at approximately $5,527,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Two […]

StockNews.com Initiates Coverage on Intersect ENT (NASDAQ:XENT) - Vimarsana News

StockNews.com Initiates Coverage on Intersect ENT (NASDAQ:XENT)

StockNews.com assumed coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the medical equipment provider’s stock. Shares of Intersect ENT stock opened at $27.75 on Thursday. The stock has a 50 day moving average of $27.46 and a 200 day moving […]

Brokerages Set Intersect ENT, Inc. (NASDAQ:XENT) Target Price at $25.95 - Vimarsana News

Brokerages Set Intersect ENT, Inc. (NASDAQ:XENT) Target Price at $25.95

Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) has been given a consensus recommendation of “Hold” by the six brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The average 12-month price objective among brokers […]

United States Drug Eluting Sinus Stent (DESS) Market Report 2022-2025 with Profiles of Intersect ENT, Medtronic plc, Stryker Corp (Entellus Medical, Inc.), and Johnson & Johnson - Vimarsana News

United States Drug Eluting Sinus Stent (DESS) Market Report 2022-2025 with Profiles of Intersect ENT, Medtronic plc, Stryker Corp (Entellus Medical, Inc.), and Johnson & Johnson

/PRNewswire/ -- The "The US Drug Eluting Sinus Stent (DESS) Market: Analysis By Procedures (Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus...